"Among those who did encounter a breakthrough an infection, the percentages of that infection becoming asymptomatic enhanced by 63% just after one particular vaccine dose and by ninety four% after the next dose," the study's authors wrote while in the Lancet.Confusion around the FDA’s regulatory overall flexibility has led some providers to mista